Westpac Banking Corp’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-44,150
| Closed | -$1.27M | – | 873 |
|
|
2020
Q1 | $1.27M | Sell |
44,150
-2,900
| -6% | -$83.3K | 0.02% | 541 |
|
|
2019
Q4 | $3.4M | Sell |
47,050
-8,400
| -15% | -$606K | 0.04% | 452 |
|
|
2019
Q3 | $7.78M | Sell |
55,450
-5,578
| -9% | -$783K | 0.11% | 268 |
|
|
2019
Q2 | $11.2M | Sell |
61,028
-6,926
| -10% | -$1.27M | 0.17% | 157 |
|
|
2019
Q1 | $10.8M | Sell |
67,954
-14,136
| -17% | -$2.25M | 0.18% | 162 |
|
|
2018
Q4 | $7.86M | Buy |
82,090
+917
| +1% | +$87.8K | 0.13% | 208 |
|
|
2018
Q3 | $11.5M | Sell |
81,173
-13,300
| -14% | -$1.88M | 0.2% | 147 |
|
|
2018
Q2 | $14.8M | Buy |
94,473
+5,847
| +7% | +$915K | 0.28% | 105 |
|
|
2018
Q1 | $14.3M | Buy |
88,626
+16,687
| +23% | +$2.69M | 0.29% | 102 |
|
|
2017
Q4 | $11.8M | Buy |
71,939
+29,130
| +68% | +$4.8M | 0.27% | 108 |
|
|
2017
Q3 | $2.67M | Buy |
+42,809
| New | +$2.67M | 0.06% | 364 |
|